PTC Therapeutics: Multiple Regulatory Submissions Along With Data Cuts
…
28,900€
-0,34%
Echtzeit-Aktienkurs PTC Therapeutics Inc.
Bid:
Ask:
Nachrichten zur PTC Therapeutics Inc. Aktie
Earnings call: PTC Therapeutics reports strong first quarter financials By Investing.com
Earnings call: PTC Therapeutics reports strong first quarter financials…
PTC Therapeutics, Inc. (PTCT) Q1 2024 Earnings Call Transcript
…
PTC Therapeutics (PTCT) Up on Positive Regulatory Updates
PTC Therapeutics (PTCT) submits BLA for gene therapy Upstaza to the FDA and announces plans to resubmit its application for…
Earnings call: PTC Therapeutics reports strong growth and pipeline progress By Investing.com
Earnings call: PTC Therapeutics reports strong growth and pipeline progress…
PTC Therapeutics, Inc. (PTCT) Q4 2023 Earnings Call Transcript
…
PTC Therapeutics says total unaudited FY23 net revenue was about $946M
…
PTC Therapeutics posts 35% revenue growth in 2023 By Investing.com
PTC Therapeutics posts 35% revenue growth in 2023…
C4 Therapeutics stock soars on Merck partnership, license deal
C4 Therapeutics Inc shares surged 93% to $2.28 in early trading on Tuesday after the clinical-stage biopharmaceutical company announced an…
PTC Therapeutics issues EU, US regulatory updates on Translarna
…
PTC Therapeutics, Inc. (PTCT) Q3 2023 Earnings Call Transcript
…
PTC Therapeutics stock slides after Citi downgrades to Sell
…
: PTC Therapeutics stock jumps on royalty deal worth up to $1.5 billion
Shares gain 12% as PTC says proceeds of deal will be used to retire debt…
Royalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics’ Royalty on Evrysdi
NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) announced today an agreement with…
PTC Therapeutics (PTCT) Moves 5.3% Higher: Will This Strength Last?
PTC Therapeutics (PTCT) saw its shares surge in the last session with trading volume being higher than average. The latest…
PTC Therapeutics (PTCT) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for PTC Therapeutics (PTCT) give a sense of how the business performed in the…
PTC Therapeutics (PTCT) Reports Q2 Loss, Misses Revenue Estimates
PTC Therapeutics (PTCT) delivered earnings and revenue surprises of -68.35% and 0.07%, respectively, for the quarter ended June 2023. Do…
PTC Therapeutics Provides Corporate Update and Reports Second Quarter Financial Results
– Second-quarter 2023 total revenue of $214 million, representing 29% year-over-year growth – – Positive APHENITY and PIVOT-HD data readouts…
PTC Therapeutics Q2 2023 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
PTC Therapeutics appoints Pierre Gravier as finance chief
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K PTC THERAPEUTICS, INC. For: Jul 13
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
PTC Therapeutics Appoints Experienced Healthcare Finance Strategist Pierre Gravier as Chief Financial Officer
SOUTH PLAINFIELD, N.J., July 17, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the appointment of Pierre Gravier…
PTC Therapeutics Announces Virtual Presentation on Phenylketonuria (PKU) and Sepiapterin
SOUTH PLAINFIELD, N.J., July 11, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT), announced today that the company will provide…
PTC Therapeutics seizure candidate vatiquinone misses primary endpoint
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K PTC THERAPEUTICS, INC. For: Jun 21
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Enveric, Zura top healthcare gainers; PTC Therapeutics, CohBar lead losers pack
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
PTC Therapeutics Shares Fall 21% as Co. Discontinues Some Programs in Gene Therapy
PTC Therapeutics Shares Fall 21% as Co. Discontinues Some Programs in Gene Therapy...…
Form 8-K PTC THERAPEUTICS, INC. For: May 20
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insiderhandel: CHIEF BUSINESS OFFICER verkauft Aktien von PTC Therapeutics im Wert von 118.791$
Pauwels, Eric - Vorstand - Tag der Transaktion: 2023-05-22...…
Insiderhandel: CHIEF BUSINESS OFFICER verkauft Aktien von PTC Therapeutics im Wert von 377.491$
Pauwels, Eric - Vorstand - Tag der Transaktion: 2023-05-19...…
PTC Therapeutics Announces Strategic Pipeline Prioritization
- Preclinical and early research gene therapy programs discontinued - - Expected reductions of approximately 15% in residual 2023 OPEX…
PTC Therapeutics Announces Topline Results from Vatiquinone MOVE-FA Registration-Directed Trial
- Conference call and webcast to be held at 5:00 pm EDT - SOUTH PLAINFIELD, N.J., May 23, 2023 /PRNewswire/…
Insiderhandel: CHIEF BUSINESS OFFICER verkauft Aktien von PTC Therapeutics im Wert von 470.822$
Pauwels, Eric - Vorstand - Tag der Transaktion: 2023-05-17...…
Insiderhandel: CHIEF BUSINESS OFFICER verkauft Aktien von PTC Therapeutics im Wert von 46.267$
Pauwels, Eric - Vorstand - Tag der Transaktion: 2023-05-18...…
PTC Therapeutics Announces APHENITY Trial Achieved Primary Endpoint with Sepiapterin in PKU Patients
- Highly statistically significant and clinically meaningful results - - 63% mean blood Phe reduction in primary analysis population (p...…
Form 8-K PTC THERAPEUTICS, INC. For: May 17
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
PTC Therapeutics (PTCT) Upgraded to Buy: What Does It Mean for the Stock?
PTC Therapeutics (PTCT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to…
PTC Therapeutics Q1 2023 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insiderhandel: SVP, FINANCE & CAO verkauft Aktien von PTC Therapeutics im Wert von 258.326$
Utter, Christine Marie - Vorstand - Tag der Transaktion: 2023-04-21...…
Insiderhandel: Aufsichtsrat verkauft Aktien von PTC Therapeutics im Wert von 238.258$
Reeve, Emma - Aufsichtsrat - Tag der Transaktion: 2023-04-21...…
Insiderhandel: CHIEF BUSINESS OFFICER verkauft Aktien von PTC Therapeutics im Wert von 38.096$
Pauwels, Eric - Vorstand - Tag der Transaktion: 2023-04-18...…
Form 8-K PTC THERAPEUTICS, INC. For: Apr 18
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
PTC Therapeutics to Host Conference Call to Discuss First Quarter 2023 Financial Results
SOUTH PLAINFIELD, N.J., April 13, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will host…
Insiderhandel: CHIEF FINANCIAL OFFICER verkauft Aktien von PTC Therapeutics im Wert von 331.335$
Hill, Emily Luisa - Vorstand - Tag der Transaktion: 2023-03-27...…
Insiderhandel: Aufsichtsrat verkauft Aktien von PTC Therapeutics im Wert von 450.956$
Southwell, David P. - Aufsichtsrat - Tag der Transaktion: 2023-03-27...…
Insiderhandel: SVP, FINANCE & CAO verkauft Aktien von PTC Therapeutics im Wert von 1.202.105$
Utter, Christine Marie - Vorstand - Tag der Transaktion: 2023-03-27...…
PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
SOUTH PLAINFIELD, N.J., March 28, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on March 22, 2023,…
PTC Therapeutics CEO retires after 25 years of service
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K PTC THERAPEUTICS, INC. For: Mar 22
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
PTC Therapeutics Chief Executive Stuart Peltz Resigns
PTC Therapeutics Chief Executive Stuart Peltz Resigns...…